Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1985-3-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0277-6715
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
325-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6528132-BCG Vaccine,
pubmed-meshheading:6528132-Biometry,
pubmed-meshheading:6528132-Clinical Trials as Topic,
pubmed-meshheading:6528132-Humans,
pubmed-meshheading:6528132-Immunotherapy,
pubmed-meshheading:6528132-Neoplasms,
pubmed-meshheading:6528132-Random Allocation,
pubmed-meshheading:6528132-Time Factors
|
pubmed:articleTitle |
Experience with historical control studies in cancer immunotherapy.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|